Vertex Pharmaceuticals (Europe) Ltd

CIK 1761216 · last filed 2018-12-28

Vertex Pharmaceuticals (Europe) Ltd is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing shows the insider bought $2.0M of CRSP on Dec 28, 2018. Across all open-market trades the lifetime net is +$2.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $266.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$266.60M

Companies

1

Total Filings

1

Lifetime Open-Market Net

$2.00M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CRSP	10%+ Owner	5,353,479	$49.80	$266.60M	$2.00M	1	2018-12-28

Recent Filings

1 filing

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2018-12-28	CRSP	Buy (P)	+80,396	$2.00M	EDGAR

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.